(Q38584582)

reason for preferred rank

4 September 2017

Timolol in the therapy of “ocular hypertension” (English)

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

7 August 2023

Timolol in the therapy of "ocular hypertension" (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6110245

7 August 2023

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

7 August 2023

author name string

Boger WP 3rd

1

1 reference

4 September 2017

W. P. Boger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6110245

7 August 2023

R. F. Steinert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6110245

7 August 2023

J. V. Thomas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6110245

7 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6110245

7 August 2023

publication date

1 November 1980

1 reference

full work available at URL

4 September 2017

https://api.elsevier.com/content/article/PII:0039625780900983?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

https://api.elsevier.com/content/article/PII:0039625780900983?httpAccept=text/plain

7 August 2023

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

7 August 2023

published in

Survey of Ophthalmology

1 reference

4 September 2017

25

1 reference

4 September 2017

3

1 reference

4 September 2017

195-202

1 reference

The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma

4 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

The effect of metoprolol on intra-ocular pressure in glaucoma. A pilot study

7 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Recent experimental, clinical, and therapeutic research on the problems of intraocular pressure and glaucoma

7 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

The treatment of glaucoma: role of beta-blocking agents

7 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma

7 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Long-Term Experience with Timolol Ophthalmic Solution in Patients with Open-Angle Glaucoma

7 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Effect of pindolol on intraocular pressure

7 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

'Ocular hypertension' vs open-angle glaucoma

7 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

7 August 2023

17

95

1083

1977

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker

7 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Perspectives in adrenergic beta-receptor blockade

7 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Creatine phosphokinase MB band in oculopharyngeal muscular dystrophy

7 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution

7 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Timolol Therapy in Secondary Angle-Closure Glaucoma Post Penetrating Keratoplasty

7 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Comparison of ocular hypotensive effects of acetazolamide and atenolol

7 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose

7 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Adverse effects experienced by patients taking timolol

7 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

A Comparison of the Effects of Timolol and Epinephrine on Intraocular Pressure

7 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Clinical experience with propranolol in the treatment of glaucoma

7 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Atenolol eye drops in glaucoma: a double-masked, controlled study

7 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Propranolol as ocular hypotensive agent

7 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Timolol. A new drug for management of chronic simple glaucoma

7 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Outflow resistance and adrenergic mechanisms. Effects of sympathectomy, N-(2-chloroethyl) dibenzylamine hydrochloride (dibenamine) and dichloroiso-proterenol on the outflow resistance of the rabbit eye

7 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

The effect of some beta-adrenergic blockers on human intraocular pressure.

7 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Ocular and cardiovascular effects of local and systemic pindolol

7 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Timolol and epinephrine. Comparisin of efficacy and side effects

7 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Stereospecific binding of timolol, a beta-adrenergic blocking agent

7 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Practolol (Eraldin) eye drops as an ocular hypotensive agent

7 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Topical propranolol and ocular tension in the human

7 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Adverse reactions from timolol administration

7 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Corneal anesthesia after timolol maleate therapy

7 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers

7 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Effect of topical atenolol on intraocular pressure

7 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Timolol: Its Effectiveness in Different Types of Glaucoma

7 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Timolol, dose response and duration of action

7 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

7 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90098-3

7 August 2023

Identifiers

1 reference

4 September 2017

1 reference